The Society for Immunotherapy of Cancer's (SITC) Advances in Cancer Immunotherapy™ (ACI) 2019-2020 programs are CME-, CPE-, CNE- and MOC-certified regional educational meetings featuring nearly five hours of engaging cancer immunotherapy education, with more time devoted to each topic than ever before. This 2019-2020 programs also provides online, CME-, CPE-, CNE- and MOC-certified companion activities, which are accessible independently by those unable to attend in-person meetings or serve as helpful references for attendees as they incorporate what they learned into practice.
ACIs are free for healthcare professionals in the clinical setting, students and patient advocates. They are presented by local authorities in tumor immunology and cancer immunotherapy and cover the following topics:
- An introduction to cancer immunotherapy: learn about the basic principles behind cancer immunotherapy
- Immunotherapy in practice: attend sessions on lung cancer, skin cancers, head and neck cancers, genitourinary cancers, hematologic malignancies, and other solid tumors including breast and gynecologic cancers, MSI-high tumors and hepatocellular carcinoma
- An overview of cancer immunotherapy associated toxicities, including uncommon and rare immune-related adverse events (irAEs)
- Barriers in practice: recognize barriers to cancer immunotherapy
- The future of cancer immunotherapy: understand trends, developments, potential approvals and disease states with promising data